Malonic Acid (malonate in its ionized form) is an organic dicarboxylic acid measured in urine organic acid panels. Biochemically it is distinct from malonyl‑CoA (the two‑carbon donor in fatty acid synthesis) but is related in metabolic pathways and can arise from endogenous metabolism, diet, or microbial activity. Historically, malonate has been used experimentally as a competitive inhibitor of succinate dehydrogenase (complex II) in the Krebs cycle, so its presence has long been tied to altered Krebs cycle flux. Clinically, urinary malonic acid is interpreted as a metabolic marker that complements other organic acids, mitochondrial indicators, and oxidative stress measures to map cellular energy handling.

Elevated urinary malonic acid may reflect a bottleneck or altered flow through the Krebs cycle, interference with succinate dehydrogenase activity, shifts in fatty acid or odd‑chain metabolism, or contributions from microbial metabolism. Higher levels are often evaluated alongside other mitochondrial and oxidative markers to understand whether the pattern points to cellular energy strain or metabolic dysregulation. Low or undetectable malonic acid is common and typically indicates no detectable excess malonate production; low values should be read in context — they do not alone confirm efficient mitochondrial function and may reflect normal variation, sample timing, or dietary factors. Interpretation is most informative when combined with the full Cellular Zoomer profile and clinical history.

Malonic Acid is included in the Cellular Zoomer because it reports on Krebs cycle integrity and potential inhibition at complex II. Measured with other organic acids, oxidative damage markers, and antioxidant genetics, malonate helps reveal patterns of mitochondrial strain and metabolic imbalance to support personalized interpretation and follow‑up testing.